The risk factors for a poor hematopoietic stem cell mobilization in lymphoma patients

Volume: 56 Number: 1 March 1, 2017
  • Asu Fergün Yılmaz
  • Murat Tombuloglu
  • Ayhan Dönmez
Ege Journal of Medicine Cover
Ege Journal of Medicine
PDF Download
EN TR

The risk factors for a poor hematopoietic stem cell mobilization in lymphoma patients

Abstract

Aim: Poor mobilization is an important problem in autologous stem cell transplantation. The ratio of poor mobilization is higher in lymphoma patients. There is limited data about poor mobilization in lymphoma patients. We aimed to identify the possible risk factors for poor mobilization using data from 57 lymphoma patients. Materials and Methods: We retrospectively reviewed the data of 57 lymphoma patients (40 with non-Hodgkin lymphoma and 17 with Hodgkin lymphoma) who have been mobilized during 1998 - 2011. Patient data were recruited from the archives of the hematology clinic. Results: We documented poor mobilization in 13 (22.8%) patients. Bone marrow involvement (odds ratio [OR] =15.52, p=0.002) and being treated with more than ten cycles of chemotherapies (OR=6.25, p=0.04) were found to be possible risk factors. Conclusion: Leukapheresis staff should be aware of the increased risk of poor mobilization in these cases and remobilization strategies should be considered from the beginning in these patients with risk factors for more effective resource utilization.

Keywords

Details

Primary Language

Turkish

Subjects

-

Journal Section

-

Authors

Asu Fergün Yılmaz

Murat Tombuloglu

Ayhan Dönmez

Publication Date

March 1, 2017

Submission Date

March 1, 2017

Acceptance Date

-

Published in Issue

Year 2017 Volume: 56 Number: 1

DOI

https://doi.org/10.19161/etd.344290

IZ

https://izlik.org/JA26AH66BJ

Cite

RIS / Bibtex
Vancouver
1.Asu Fergün Yılmaz, Murat Tombuloglu, Ayhan Dönmez. Lenfoma hastalarında yetersiz hematopoiteik kök hücre mobilizasyonu için risk faktörleri. EJM. 2017 Mar. 1;56(1):6-10. doi:10.19161/etd.344290

Ege Journal of Medicine enables the sharing of articles according to the Attribution-Non-Commercial-Share Alike 4.0 International (CC BY-NC-SA 4.0) license.